Home
Browse All Titles
Sign In
Browse All Titles
Pharmacy Practice and the Law
About
Table of Contents
Main Index
Case Studies
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com:11002?IndexTerms-page=3
◀
*
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
Y
Z
▶
View All
consultant pharmacists
Harder v. F. C. Clinton, Inc.
Labeling of Drugs and Biologicals
consumer information
consumer medication information (CMI)
Consumer Product Safety Commission (CPSC)
Consumer Value Stores (CVS)
continuing education programs
continuing pharmacy education (CPE)
continuous quality improvement (CQI) programs
An Alternative Approach to Regulation
Continuous Quality Improvement Programs as Risk Management
contraceptives, emergency (Plan B)
contract pharmacies
contraindications, labels
contributory negligence
Controlled Substance Ordering System (CSOS)
Controlled Substance Registrant Protection Act (1984)
Controlled Substances Act (CSA)
controlled substances distribution
Anabolic Steroids Act (2004)
authority for scheduling
Chemical Diversion and Trafficking Act (1988)
Combat Methamphetamine Epidemic Act (2005)
Controlled Substance Registrant Protection Act (1984)
manufacturer labeling and packaging
Methamphetamine Prevention Act (2008)
Narcotic Addict Treatment Act (1974)
overview
U.S. Postal Laws
corporate negligence
corporate officer liability
correcting
corrections to prescriptions
corresponding responsibility doctrine
Purpose of a Controlled Substance Prescription
United States v. Hayes
cosmetics
drugs vs.
Drugs vs Cosmetics
FDA definitions, overview
FDA regulations
federal regulations, overview
prohibited acts, penalties, and enforcement, FDCA
cost concerns, Medicaid reimbursement
counseling patients
counterfeit drugs
Corporate Officer Liability
Defining and Distinguishing Drugs from Foods, Dietary Supplements, Devices, and Cosmetics
Prescription Drug Marketing Act of 1987
courts, law made by
covered entities
340B Drugs
Health Insurance Portability and Accountability Act of 1996
Use and Disclosure of PHI; Right to Access
See continuing pharmacy education (CPE)
Continuing Education
Licensing
Licensing of Pharmacists
See continuing pharmacy education (CPE)
Standards of Practice
See Compliance Policy Guide (CPG)
Bibliography
FDA 1992 Compliance Policy Guide: Later Rescinded by FDAMA
FDAMA's Compounding Provisions (§ 503A): Later Reinstated as § 503A Under the DQSA
Inspections Under the Federal Food, Drug, and Cosmetic Act
Marketed Unapproved Drugs
Pharmacy Compounding vs Manufacturing
Prescription Drug Labels and Labeling
Prescription Drug Marketing Act of 1987
See Compliance Policy Guide (CPG)
United States v. Hiland
See continuous quality improvement (CQI) programs
Continuous Quality Improvement Programs
Continuous Quality Improvement Programs as Risk Management
Nelms v. Walgreen Co.
Regulation for Outcomes
Risk Management Strategies
See continuous quality improvement (CQI) programs
The Pharmacist as Risk Manager
Walgreen Co. v. Selcke
Refresh
first
prev
1
2
3
4
30
select
next
last
Displaying items 61 - 90 of 100